Bevacizumab versus ranibizumab for neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials.

Purpose:To evaluate the relative efficacy and safety of bevacizumab versus ranibizumab for the treatment of the neovascular form of age-related macular degeneration.Methods:A comprehensive literature search using the Cochrane Methodology Register to identify randomized controlled trials comparing be